The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gala Renee D since 2015.
This trader's CIK number is 1607737.
At the time of last reporting, Gala Renee D was the EVP & Chief Financial Officer of Jazz Pharmaceuticals Plc. (stock ticker symbol JAZZ).
Also see all insider trading activities at Jazz Pharmaceuticals Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | CORT | 10,000 | $155,106 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | TBPH | 0 | $0 | 53,743 | $1,428,352 | 0 | $0 |
| 2015 | TBPH | 10,000 | $121,750 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | JAZZ | 0 | $0 | 6,000 | $790,476 | 0 | $0 |
1. Corcept Therapeutics Inc (CORT)
2. Theravance Biopharma, Inc. (TBPH)
3. Jazz Pharmaceuticals Plc (JAZZ)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-03-07 | CORT | Buy | 9,000 | 15.53 | 139,806 |
| 2018-03-06 | CORT | Buy | 1,000 | 15.30 | 15,300 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-15 | TBPH | Sale | 41,539 | 27.07 | 1,124,336 |
| 2018-08-14 | TBPH | Sale | 2,204 | 27.74 | 61,136 |
| 2018-05-18 | TBPH | Sale | 10,000 | 24.29 | 242,880 |
| 2015-08-17 | TBPH | Buy | 5,000 | 12.16 | 60,800 |
| 2015-08-13 | TBPH | Buy | 5,000 | 12.19 | 60,950 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-18 | JAZZ | Sale | 6,000 | 131.75 | 790,476 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gala Renee D (EVP & Chief Financial Officer of Jazz Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.